Delve into the field of PARP inhibitors, a class that has gained traction in ovarian, breast, and prostate cancers.
1don MSN
New clues to hepatitis B species restriction could help build a novel model for studying infection
Some 254 million people live with a chronic hepatitis B (HBV) infection that is often asymptomatic for decades, only to ...
More than 250 million people worldwide live with chronic hepatitis B (HBV), yet there is still no accessible animal model for studying the disease or testing novel therapies. Researchers have now ...
Recognising impressive contribution and transformative impact across the molecular biosciences, the Biochemical Society has ...
NDMA—a carcinogen that has been found in medications and in drinking water contaminated by chemical plants—may have a much ...
Some 254 million people live with a chronic hepatitis B (HBV) infection that is often asymptomatic for decades, only to ...
Scientists from Skoltech (part of the VEB.RF group) and the University of Potsdam have developed a physical theory that sheds light on how molecular motors organize the three-dimensional structure of ...
PBGENE-HBV is Precision's wholly owned in vivo gene editing program under investigation in a global first-in-human clinical trial, which is designed to be a potentially curative treatment for chronic ...
Irish Examiner on MSN
What the world’s leading ageing scientists taught me about diet and living longer
Processed foods are increasingly linked to a higher risk of disease and may accelerate physical and cognitive decline, ...
Scientists have discovered that a protein linked to cell death is secretly driving the aging of blood stem cells in a ...
As people get older, their blood and immune systems gradually lose strength. A major reason is the decline of hematopoietic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results